<code id='9074790C1D'></code><style id='9074790C1D'></style>
    • <acronym id='9074790C1D'></acronym>
      <center id='9074790C1D'><center id='9074790C1D'><tfoot id='9074790C1D'></tfoot></center><abbr id='9074790C1D'><dir id='9074790C1D'><tfoot id='9074790C1D'></tfoot><noframes id='9074790C1D'>

    • <optgroup id='9074790C1D'><strike id='9074790C1D'><sup id='9074790C1D'></sup></strike><code id='9074790C1D'></code></optgroup>
        1. <b id='9074790C1D'><label id='9074790C1D'><select id='9074790C1D'><dt id='9074790C1D'><span id='9074790C1D'></span></dt></select></label></b><u id='9074790C1D'></u>
          <i id='9074790C1D'><strike id='9074790C1D'><tt id='9074790C1D'><pre id='9074790C1D'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:1581
          Glaxo Smith Kline
          Akira Suemori/AP

          A few years ago, Vijay Pande, then a professor at Stanford who was using computer science to understand biology, was deciding whether to leave full-time academic work to become a venture capitalist. He turned to Andrew Ng, another Stanford professor who had joined Google Brain and later the Chinese search firm Baidu.

          “The things that we dreamed about five or 10 years ago were happening now,” Pande recalled Ng telling him. “The question was, do you want to be a part of it? Or do you want to write another paper?”

          advertisement

          Pande decided to become a venture capitalist. The result, he told an audience at a STAT event in San Francisco last week, is that, whereas he managed about $1 million to $2 million in research as a top academic, he now works at the fabled Silicon Valley firm Andreessen Horowitz, which invests $100 million a year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Using force crossed my mind when examining a defiant young patient
          Using force crossed my mind when examining a defiant young patient

          Inthis1895photo,nursesanddoctorsinoculateachildwithdiphtheriaantitoxinatthePasteurInstituteinNewYork

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Children’s Hospital revives plan for pedestrian bridge

          ArenderingoftheLongwoodAvenuefootbridgeBostonChildren’sHospitalplanstobuild.Elkus/ManfrediArchitects